{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:03:43Z","timestamp":1789646623734,"version":"4.0.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ejogrb.2026.115396","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T06:52:35Z","timestamp":1787813555000},"page":"115396","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Ovarian borderline tumors and minimally invasive surgery: a narrative review"],"prefix":"10.1016","volume":"326","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0326-3311","authenticated-orcid":false,"given":"Tiffany","family":"Redfern","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo Nicol\u00e1s","family":"Gola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"Erazo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khadija","family":"Warfa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Alrubaish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1060-337X","authenticated-orcid":false,"given":"Vaishali","family":"Paliwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Chudi","family":"Ezeanochie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2026.115396_b0005","doi-asserted-by":"crossref","DOI":"10.3389\/fsurg.2022.973034","article-title":"The challenging management of borderline ovarian tumors (BOTs) in women of childbearing age","volume":"9","author":"Della Corte","year":"2022","journal-title":"Front Surg"},{"issue":"1","key":"10.1016\/j.ejogrb.2026.115396_b0010","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13048-016-0276-1","article-title":"Borderline ovarian tumors: clinical characteristics, management, and outcomes - a multicenter study","volume":"9","author":"Gokcu","year":"2016","journal-title":"J Ovarian Res"},{"issue":"5","key":"10.1016\/j.ejogrb.2026.115396_b0015","first-page":"471","article-title":"Diagnosis and treatment of borderline ovarian neoplasms \u201cthe state of the art\u201d","volume":"30","author":"Trope","year":"2009","journal-title":"Eur J Gynaecol Oncol"},{"issue":"13","key":"10.1016\/j.ejogrb.2026.115396_b0020","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11133645","article-title":"Risk factors for recurrence of borderline ovarian tumours after conservative surgery and impact on fertility: a multicentre study by the francogyn group","volume":"11","author":"Ozenne","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.ejogrb.2026.115396_b0025","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.3332\/ecancer.2020.1031","article-title":"Borderline ovarian tumours: management in the era of fertility-sparing surgery","volume":"14","author":"Maramai","year":"2020","journal-title":"Ecancermedicalscience"},{"issue":"3","key":"10.1016\/j.ejogrb.2026.115396_b0030","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.bpobgyn.2011.12.006","article-title":"Borderline ovarian tumours","volume":"26","author":"Trope","year":"2012","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"4","key":"10.1016\/j.ejogrb.2026.115396_b0035","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3802\/jgo.2015.26.4.343","article-title":"Controversies in borderline ovarian tumors","volume":"26","author":"Seong","year":"2015","journal-title":"J Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ejogrb.2026.115396_b0040","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ejca.2005.07.029","article-title":"Borderline tumours of the ovary and fertility","volume":"42","author":"Morice","year":"2006","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.ejogrb.2026.115396_b0045","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ygyno.2017.01.002","article-title":"Parity, infertility, oral contraceptives, and hormone replacement therapy and the risk of ovarian serous borderline tumors: a nationwide case-control study","volume":"144","author":"Rasmussen","year":"2017","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejogrb.2026.115396_b0050","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/his.13977","article-title":"Revising the WHO classification: female genital tract tumours","volume":"76","author":"Cree","year":"2020","journal-title":"Histopathology"},{"issue":"Suppl 2","key":"10.1016\/j.ejogrb.2026.115396_b0055","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/S0893-3952(22)04457-X","article-title":"Borderline epithelial tumors of the ovary","volume":"18","author":"Hart","year":"2005","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.ejogrb.2026.115396_b0060","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1080\/00016340801995640","article-title":"Prognostic significance of the micropapillary pattern in patients with serous borderline ovarian tumors","volume":"87","author":"Chang","year":"2008","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"11","key":"10.1016\/j.ejogrb.2026.115396_b0065","first-page":"6725","article-title":"Long-term follow-up of borderline ovarian tumors clinical outcome and prognostic factors","volume":"34","author":"Lazarou","year":"2014","journal-title":"Anticancer Res"},{"issue":"4","key":"10.1016\/j.ejogrb.2026.115396_b0070","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/00000478-200404000-00009","article-title":"Grading ovarian serous carcinoma using a two-tier system","volume":"28","author":"Malpica","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejogrb.2026.115396_b0075","doi-asserted-by":"crossref","unstructured":"Berek JS, Renz M, Kehoe S, Kumar L, Friedlander M. Cancer of the ovary, fallopian tube, and peritoneum: 2021 update. Int J Gynaecol Obstet. 2021;155 Suppl 1(Suppl 1):61\u201385.","DOI":"10.1002\/ijgo.13878"},{"issue":"6","key":"10.1016\/j.ejogrb.2026.115396_b0080","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/jnci\/95.6.484","article-title":"Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma","volume":"95","author":"Singer","year":"2003","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.ejogrb.2026.115396_b0085","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/modpathol.2017.121","article-title":"KRAS mutation of extraovarian implants of serous borderline tumor: prognostic indicator for adverse clinical outcome","volume":"31","author":"Zuo","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ejogrb.2026.115396_b0090","doi-asserted-by":"crossref","unstructured":"Drymiotou S, Theodorou E, Rallis KS, Nicolaides M, Sideris M. Molecular Biomarkers in Borderline Ovarian Tumors: Towards Personalized Treatment and Prognostic Assessment. Cancers (Basel). 2025;17(3).","DOI":"10.3390\/cancers17030545"},{"issue":"1","key":"10.1016\/j.ejogrb.2026.115396_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijgc.2024.100022","article-title":"Liquid biopsy for diagnosing epithelial ovarian cancer: quantification of cell-free DNA and p53 mutational analysis","volume":"35","author":"Rajaram","year":"2025","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.ejogrb.2026.115396_b0100","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/0002-9378(94)90105-8","article-title":"Accuracy of frozen-section (intraoperative consultation) diagnosis of ovarian tumors","volume":"171","author":"Rose","year":"1994","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ejogrb.2026.115396_b0105","first-page":"577","article-title":"Accuracy of intraoperative frozen section in diagnosis of ovarian tumors","volume":"89","author":"Wootipoom","year":"2006","journal-title":"J Med Assoc Thai"},{"issue":"16","key":"10.1016\/j.ejogrb.2026.115396_b0110","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.7150\/jca.25883","article-title":"Diagnostic accuracy of frozen section analysis of borderline ovarian tumors: a meta-analysis with emphasis on misdiagnosis factors","volume":"9","author":"Huang","year":"2018","journal-title":"J Cancer"},{"issue":"4","key":"10.1016\/j.ejogrb.2026.115396_b0115","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/PGP.0000000000000821","article-title":"Comparison of frozen and permanent section diagnosis in ovarian neoplasms: analysis of factors affecting accuracy","volume":"41","author":"Akbarzadeh-Jahromi","year":"2022","journal-title":"Int J Gynecol Pathol"},{"issue":"1","key":"10.1016\/j.ejogrb.2026.115396_b0120","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ygyno.2011.03.021","article-title":"Accuracy of frozen section diagnosis of borderline ovarian tumors","volume":"122","author":"Song","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2026.115396_b0125","unstructured":"Network NCC. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae): Ovarian Cancer\/Fallopian Tube Cancer\/Primary Peritoneal Cancer. Version 4.2026. Plymouth Meeting, PA: National Comprehensive Cancer Network; 2026."},{"issue":"5","key":"10.1016\/j.ejogrb.2026.115396_b0130","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1097\/IGC.0b013e31821bec6b","article-title":"Recommendations of the fertility task force of the european society of gynecologic oncology about the conservative management of ovarian malignant tumors","volume":"21","author":"Morice","year":"2011","journal-title":"Int J Gynecol Cancer"},{"issue":"5","key":"10.1016\/j.ejogrb.2026.115396_b0135","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/IGC.0000000000000140","article-title":"The value of random biopsies, omentectomy, and hysterectomy in operations for borderline ovarian tumors","volume":"24","author":"Kristensen","year":"2014","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.ejogrb.2026.115396_b0140","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1186\/s12885-020-07262-w","article-title":"Staging procedures fail to benefit women with borderline ovarian tumours who want to preserve fertility: a retrospective analysis of 448 cases","volume":"20","author":"Li","year":"2020","journal-title":"BMC Cancer"},{"issue":"12","key":"10.1016\/j.ejogrb.2026.115396_b0145","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1634\/theoncologist.2012-0139","article-title":"Diagnosis, treatment, and follow-up of borderline ovarian tumors","volume":"17","author":"Fischerova","year":"2012","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.ejogrb.2026.115396_b0150","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1245\/s10434-010-1293-8","article-title":"Prognostic factors of a large retrospective series of mucinous borderline tumors of the ovary (excluding peritoneal pseudomyxoma)","volume":"18","author":"Koskas","year":"2011","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejogrb.2026.115396_b0155","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14061485","article-title":"Fertility sparing surgery and borderline ovarian tumours","volume":"14","author":"Kasaven","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejogrb.2026.115396_b0160","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.bpobgyn.2016.09.012","article-title":"Management of borderline ovarian tumours","volume":"41","author":"Gershenson","year":"2017","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"2","key":"10.1016\/j.ejogrb.2026.115396_b0165","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/humupd\/dms047","article-title":"Fertility and borderline ovarian tumor: a systematic review of conservative management, risk of recurrence and alternative options","volume":"19","author":"Darai","year":"2013","journal-title":"Hum Reprod Update"},{"issue":"3","key":"10.1016\/j.ejogrb.2026.115396_b0170","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ygyno.2017.01.019","article-title":"Role of hysterectomy and lymphadenectomy in the management of early-stage borderline ovarian tumors","volume":"144","author":"Matsuo","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2026.115396_b0175","doi-asserted-by":"crossref","unstructured":"Wetterwald L, Sarivalasis A, Liapi A, Mathevet P, Achtari C. Lymph Node Involvement in Recurrent Serous Borderline Ovarian Tumors: Current Evidence, Controversies, and a Review of the Literature. Cancers (Basel). 2023;15(3).","DOI":"10.3390\/cancers15030890"},{"issue":"6","key":"10.1016\/j.ejogrb.2026.115396_b0180","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1136\/ijgc-2023-005214","article-title":"Role of fertility-sparing surgery and further prognostic factors in borderline tumors of the ovary","volume":"34","author":"Westermann","year":"2024","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"10.1016\/j.ejogrb.2026.115396_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijgc.2025.101666","article-title":"Prognosis and fertility of stage II to IV borderline ovarian tumors after fertility-sparing surgery","volume":"35","author":"Zheng","year":"2025","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.ejogrb.2026.115396_b0190","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ygyno.2016.05.005","article-title":"Relapse and disease specific survival in 1143 danish women diagnosed with borderline ovarian tumours (BOT)","volume":"142","author":"Karlsen","year":"2016","journal-title":"Gynecol Oncol"},{"issue":"22","key":"10.1016\/j.ejogrb.2026.115396_b0195","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15225327","article-title":"Fertility and pregnancy outcomes after fertility-sparing surgery for early-stage borderline ovarian tumors and epithelial ovarian cancer: a single-center study","volume":"15","author":"Ko","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejogrb.2026.115396_b0200","first-page":"403","article-title":"Management of borderline ovarian tumours: a comprehensive review of the literature","volume":"8","author":"Abascal-Saiz","year":"2014","journal-title":"Ecancermed Sci"},{"issue":"3","key":"10.1016\/j.ejogrb.2026.115396_b0205","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ygyno.2017.03.019","article-title":"Minimally invasive compared with open surgery in patients with borderline ovarian tumors","volume":"145","author":"Song","year":"2017","journal-title":"Gynecol Oncol"},{"issue":"11","key":"10.1016\/j.ejogrb.2026.115396_b0210","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12113831","article-title":"Minimally invasive staging of early-stage epithelial ovarian cancer versus open surgery in terms of feasibility and safety: a systematic review and meta-analysis","volume":"12","author":"Ronsini","year":"2023","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.ejogrb.2026.115396_b0215","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.jmig.2017.02.013","article-title":"Minimally invasive surgical staging in early-stage ovarian carcinoma: a systematic review and meta-analysis","volume":"24","author":"Bogani","year":"2017","journal-title":"J Minim Invasive Gynecol"},{"issue":"1","key":"10.1016\/j.ejogrb.2026.115396_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2013.04.013","article-title":"Staging laparoscopy for the management of early-stage ovarian cancer: a metaanalysis","volume":"209","author":"Park","year":"2013","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ejogrb.2026.115396_b0270","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/annonc\/mdh149","article-title":"Clinical outcome after laparoscopic pure management of borderline ovarian tumors: results of a series of 34 patients","volume":"15","author":"Camatte","year":"2004","journal-title":"Ann Oncol"},{"issue":"9","key":"10.1016\/j.ejogrb.2026.115396_b0230","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1097\/IGC.0000000000001358","article-title":"Comparison of laparoscopic and open surgery for patients with borderline ovarian tumors","volume":"28","author":"Jung","year":"2018","journal-title":"Int J Gynecol Cancer"},{"issue":"12","key":"10.1016\/j.ejogrb.2026.115396_b0225","doi-asserted-by":"crossref","first-page":"7616","DOI":"10.1245\/s10434-021-09852-9","article-title":"Status of surgical management of borderline ovarian tumors in france: are recommendations being followed? multicentric french study by the FRANCOGYN Group","volume":"28","author":"Lecointre","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejogrb.2026.115396_b0250","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.583515","article-title":"Feasibility of single-port access (SPA) laparoscopy for large ovarian tumor suspected to be borderline ovarian tumor","volume":"10","author":"Kang","year":"2020","journal-title":"Front Oncol"},{"issue":"3","key":"10.1016\/j.ejogrb.2026.115396_b0240","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.3802\/jgo.2025.36.e46","article-title":"Oncological safety of minimally invasive surgery in borderline ovarian tumor and ovarian cancer: a retrospective comparative study","volume":"36","author":"Osawa","year":"2025","journal-title":"J Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.ejogrb.2026.115396_b0235","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/1471-0528.13840","article-title":"Serous and mucinous borderline ovarian tumours: differences in clinical presentation, high-risk histopathological features, and lethal recurrence rates","volume":"123","author":"Vasconcelos","year":"2016","journal-title":"BJOG"},{"issue":"12","key":"10.1016\/j.ejogrb.2026.115396_b0245","doi-asserted-by":"crossref","first-page":"277","DOI":"10.31083\/j.ceog5012277","article-title":"Update of laparoscopic surgery in borderline ovarian tumor: systematic review","volume":"50","author":"Rotondella","year":"2023","journal-title":"Clin Exp Obstet Gynecol"},{"issue":"9","key":"10.1016\/j.ejogrb.2026.115396_b0255","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1097\/IGC.0000000000001092","article-title":"Prognostic factors for recurrence after fertility-preserving surgery in patients with borderline ovarian tumors: a systematic review and meta-analysis of observational studies","volume":"27","author":"Jiao","year":"2017","journal-title":"Int J Gynecol Cancer"},{"issue":"5","key":"10.1016\/j.ejogrb.2026.115396_b0260","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s00404-020-05716-x","article-title":"Unilateral cystectomy and serous histology are associated with relapse in borderline ovarian tumor patients with fertility-sparing surgery: a systematic review and meta-analysis","volume":"302","author":"Li","year":"2020","journal-title":"Arch Gynecol Obstet"},{"issue":"2","key":"10.1016\/j.ejogrb.2026.115396_b0265","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/IGC.0000000000001170","article-title":"Short-term outcomes and pregnancy rate after laparoscopic fertility-sparing surgery for borderline ovarian tumors: a single-institute experience","volume":"28","author":"Zhao","year":"2018","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejogrb.2026.115396_b0275","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1007\/s00404-020-05876-w","article-title":"Survey of current practices and opinions of German Society of Gynecologic Endoscopy members regarding the treatment of ovarian neoplasia by robotic surgery","volume":"303","author":"Zimmermann","year":"2021","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ejogrb.2026.115396_b0280","doi-asserted-by":"crossref","DOI":"10.3389\/fsurg.2025.1542486","article-title":"Transvaginal natural orifice transluminal endoscopic surgery for early-stage ovarian cancer and borderline ovarian tumors: a case series","volume":"12","author":"Kellerhals","year":"2025","journal-title":"Front Surg"},{"key":"10.1016\/j.ejogrb.2026.115396_b0285","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ejogrb.2020.11.045","article-title":"Borderline ovarian tumors: guidelines from the French national college of obstetricians and gynecologists (CNGOF)","volume":"256","author":"Bourdel","year":"2021","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"6","key":"10.1016\/j.ejogrb.2026.115396_b0290","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.tjog.2025.05.018","article-title":"Borderline ovarian tumors: Recurrence patterns and management in a single-institution retrospective study","volume":"64","author":"Tunc","year":"2025","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ejogrb.2026.115396_b0295","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12905-021-01263-y","article-title":"Recurrence characteristics and clinicopathological results of borderline ovarian tumors","volume":"21","author":"Niu","year":"2021","journal-title":"BMC Womens Health"},{"issue":"7","key":"10.1016\/j.ejogrb.2026.115396_b0300","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1093\/annonc\/mdu139","article-title":"Influence of histological subtypes on the risk of an invasive recurrence in a large series of stage I borderline ovarian tumor including 191 conservative treatments","volume":"25","author":"Uzan","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejogrb.2026.115396_b0305","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ejogrb.2020.03.023","article-title":"Impact of surgical restaging on recurrence in patients with borderline ovarian tumors: a meta-analysis","volume":"248","author":"Chevrot","year":"2020","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ejogrb.2026.115396_b0310","doi-asserted-by":"crossref","unstructured":"du Bois A, Ewald-Riegler N, de Gregorio N, Reuss A, Mahner S, Fotopoulou C, et al. Borderline tumours of the ovary: A cohort study of the Arbeitsgmeinschaft Gynakologische Onkologie (AGO) Study Group. Eur J Cancer. 2013;49(8):1905\u201314.","DOI":"10.1016\/j.ejca.2013.01.035"},{"issue":"13","key":"10.1016\/j.ejogrb.2026.115396_b0315","article-title":"Evaluation of borderline ovarian tumor recurrence rate after surgery with or without fertility-sparing approach: results of a retrospective analysis","volume":"11","author":"Pecorino","year":"2023","journal-title":"Healthcare (Basel)"},{"issue":"10","key":"10.1016\/j.ejogrb.2026.115396_b0320","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1200\/JCO.2001.19.10.2658","article-title":"Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: a prospective study","volume":"19","author":"Zanetta","year":"2001","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.ejogrb.2026.115396_b0325","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.fertnstert.2015.06.008","article-title":"Long-term follow-up of patients with an isolated ovarian recurrence after conservative treatment of epithelial ovarian cancer: review of the results of an international multicenter study comprising 545 patients","volume":"104","author":"Bentivegna","year":"2015","journal-title":"Fertil Steril"},{"issue":"11","key":"10.1016\/j.ejogrb.2026.115396_b0330","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.ejso.2010.07.004","article-title":"Impact of serum tumor marker determination on the management of women with borderline ovarian tumors: multivariate analysis of a French multicentre study","volume":"36","author":"Poncelet","year":"2010","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejogrb.2026.115396_b0335","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/annonc\/mdz062","article-title":"ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent diseasedagger","volume":"30","author":"Colombo","year":"2019","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.ejogrb.2026.115396_b0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.jogoh.2020.101965","article-title":"Borderline ovarian tumors: french guidelines from the CNGOF. Part 1. Epidemiology, biopathology, imaging and biomarkers","volume":"50","author":"Huchon","year":"2021","journal-title":"J Gynecol Obstet Hum Reprod"},{"issue":"1","key":"10.1016\/j.ejogrb.2026.115396_b0345","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1038\/s41598-023-29814-3","article-title":"Deep learning for the ovarian lesion localization and discrimination between borderline and malignant ovarian tumors based on routine MR imaging","volume":"13","author":"Wang","year":"2023","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.ejogrb.2026.115396_b0350","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/CM9.0000000000003530","article-title":"Artificial intelligence in gynecology surgery: current status, challenges, and future opportunities","volume":"138","author":"Dou","year":"2025","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.ejogrb.2026.115396_b0355","article-title":"Clinical utility of various liquid biopsy samples for the early detection of ovarian cancer: a comprehensive review","volume":"15","author":"Feng","year":"2025","journal-title":"Front Oncol"},{"issue":"35","key":"10.1016\/j.ejogrb.2026.115396_b0360","doi-asserted-by":"crossref","first-page":"37663","DOI":"10.18632\/oncotarget.5438","article-title":"Molecular profiling of low grade serous ovarian tumours identifies novel candidate driver genes","volume":"6","author":"Hunter","year":"2015","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.ejogrb.2026.115396_b0365","first-page":"1219","article-title":"Evaluation of circulating tumor DNA in patients with ovarian cancer harboring somatic PIK3CA or KRAS mutations","volume":"52","author":"Ogasawara","year":"2020","journal-title":"Cancer Res Treat"},{"issue":"10324","key":"10.1016\/j.ejogrb.2026.115396_b0370","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0140-6736(21)02175-9","article-title":"Trametinib versus standard of care in patients with recurrent low-grade serous ovarian cancer (GOG 281\/LOGS): an international, randomised, open-label, multicentre, phase 2\/3 trial","volume":"399","author":"Gershenson","year":"2022","journal-title":"Lancet"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211526004641?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211526004641?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T11:33:43Z","timestamp":1789644823000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211526004641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":74,"alternative-id":["S0301211526004641"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2026.115396","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ovarian borderline tumors and minimally invasive surgery: a narrative review","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2026.115396","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115396"}}